Core Viewpoint - The company reported a decline in revenue and net profit for the year 2024, indicating challenges in the market and operational adjustments [13][16]. Group 1: Meeting Details - The annual shareholder meeting for 2024 is scheduled for May 20, 2025, with both on-site and online voting options available [1]. - The meeting will be chaired by Chairman Cheng Hong, and various proposals will be discussed, including the annual work report and financial decisions [2][4]. Group 2: Board of Directors' Performance - The Board of Directors held four meetings in 2024, discussing 30 topics, all of which were unanimously approved [2]. - The Board emphasized strategic guidance for business transformation, focusing on enhancing operational efficiency and product innovation [6]. Group 3: Financial Performance - The company's revenue for 2024 was approximately 7.16 billion RMB, a decrease of 11.02% compared to 2023 [13]. - The net profit attributable to shareholders was a loss of approximately 46.10 million RMB, a significant decline from a profit of 180.29 million RMB in the previous year [13]. - The company reported a basic earnings per share of -0.12 RMB, down 126.67% from 0.45 RMB in 2023 [14]. Group 4: Strategic Initiatives - The company is focusing on a "natural health new snack" strategy, emphasizing product innovation and supply chain efficiency [6]. - A total of over 500 health snack products have been upgraded, covering various categories, with some products performing exceptionally well in sales [6]. Group 5: Investor Relations and Returns - The company maintained a 100% response rate to investor inquiries and conducted online performance briefings to enhance communication with investors [8]. - In June 2024, the company implemented a semi-annual dividend distribution, paying 2.49 RMB per 10 shares, totaling approximately 99.85 million RMB [8][9]. Group 6: Audit and Compliance - The financial statements for 2024 were audited by PwC, receiving a standard unqualified opinion [13]. - The Supervisory Board confirmed that the company operated in compliance with relevant laws and regulations, with no significant issues identified [10][11]. Group 7: Future Plans - The company plans to continue enhancing governance, improving operational efficiency, and maintaining effective communication with investors in the upcoming year [9].

Investment Rating - The report maintains a "Buy" investment rating for the company [5]. Core Views - The company is experiencing pressure on profits due to strategic adjustments, with a focus on lean management to improve efficiency [2][9]. - The introduction of new products is expected to drive revenue growth, particularly in the group buying segment, which saw a 19% increase in revenue [3]. - The company is actively optimizing its store model and reducing the number of underperforming stores to enhance profitability [3][9]. Financial Performance Summary - In 2024, the company reported total revenue of 7.159 billion yuan, a decrease of 11% year-on-year, with a net loss of 46 million yuan, a decline of 126% [1][11]. - The gross margin for 2024 and Q1 2025 decreased by 2 percentage points to 26.14% and 24.64%, respectively, primarily due to price reductions on certain products [2]. - The net profit margin also declined, with figures of -0.69% for 2024 and -2.10% for Q1 2025, attributed to reduced gross margins and increased asset impairments [2]. Earnings Forecast - The company is projected to launch a new brand focused on "natural healthy snacks" in 2024, which may initially pressure profits but is expected to perform well post-upgrade [4]. - Earnings per share (EPS) estimates for 2025-2027 are 0.06, 0.19, and 0.29 yuan, respectively, with corresponding price-to-earnings (PE) ratios of 198, 62, and 41 times [9][11].